Stay updated on Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial

Sign up to get notified when there's something new on the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The screenshots show minor UI adjustments and an additional version entry in the record history; no substantive changes to study details are observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T21:22:50.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now adds current date references and a study status update, while removing an older date reference.
    Difference
    1.0%
    Check dated 2025-10-20T14:19:12.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    New operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.
    Difference
    11%
    Check dated 2025-10-06T05:50:52.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-29T03:10:25.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Minor update: version bumped from v3.0.1 to v3.0.2, and a 'Back to Top' element was removed; core content remains unchanged.
    Difference
    0.7%
    Check dated 2025-09-14T19:56:11.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.7%
    Check dated 2025-09-07T16:57:58.000Z thumbnail image

Stay in the know with updates to Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib with Trastuzumab in ER+ HER2+ Breast Cancers Clinical Trial page.